known to be related to tobacco use and are clearly preventable. Despite the tobacco industry's well-worn, but slick, attempts to obfuscate, the public is aware of the health hazards associated with smoking. And yet, an estimated 25% of Americans continue to light up.
The AHCPR and CDC report that more dlan 70% of Americans who smoke visit a clinician each year, yet half of these persons report never having been urged to quit by their clinician. More than 70% indicated that they want to quit and have made at least Ol)e previous attempt to do so.
Although physicians can continue to influence elected representatives to stop dle subsidization of the tobacco industry, we can-and should-do much more in addressing the issue of smoking with our individual patients. To that end, the government guidelines provide a wealth of information and evidencebased strategies to assist us in helping our patients to overcome this powerful addiction. Among the major recommendations are:
• Every patient who smokes should be offered one or more of dle effective smoking cessation treatments currently available. • It is essential that clinicians determine and document the tobacco-use status of every patient treated in a healtllcare setting. • Brief cessation treatments are effective, and at least a minimal intervention should be provided to every patient who uses tobacco. • A dose-response relationship exists between me intensity and duration of a treatment and its effectiveness. Generally, the more intense me treatment, me more effective it is in producing long-term abstinence from tobacco. • Three treatment elements, in particular, are effective. One or more of tllem should be included in a smoking cessation treatment progranl: nicotine replacement therapy (transdermal nicotine patches or chewing gum); social support in the form of clinician-provided encouragement and assistance; and skill training/problem-solving techniques on achieving and maintaining abstinence.
As physicians, we have dle responsibility during each office visit to identify mose of our patients who use tobacco (including smokeless, or chewing tobacco) and to intervene. Yet, we alone cannot help our patients. The federal guidelines note that clinicians need the support of healthcare administrators and insurers to have a real impact on our patients' long-term smoking cessation. Clinicians should be reimbursed for counseling patients, and all insurers need to reimburse patients for pharmacotherapy. Only through tllis partnership can we send up in flames the notion dlat long-term smoking cessation is an oxymoron .•
Thomas Wesley Allen, DO

Editor in Chief
Editor's note: Copies of the clinical practice guidelines for smoking cessation may be ordered from the Government Printing Office at (202) 512-1800. A reference guide for clinicians and smoking cessation experts as well as a consumer guide are available from the Agency for Health Care Policy and Research Publications Clearinghouse at (800) 358-9295.
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